MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. (Q53099955)

11 May 2018

title

MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. (English)

1 reference

11 May 2018

1 reference

Maarten G Thomeer

1

1 reference

11 May 2018

Francois E Willemssen

2

1 reference

11 May 2018

Katharina K Biermann

3

1 reference

11 May 2018

Haroun El Addouli

4

1 reference

11 May 2018

Rob A de Man

5

1 reference

11 May 2018

Jan N Ijzermans

6

1 reference

11 May 2018

Roy S Dwarkasing

7

1 reference

11 May 2018

publication date

29 July 2013

1 reference

11 May 2018

Journal of Magnetic Resonance Imaging

published in

1 reference

11 May 2018

volume

39

1 reference

11 May 2018

issue

5

1 reference

11 May 2018

page(s)

1259-1264

1 reference

11 May 2018

Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: tumor-by-tumor analysis in explant livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Telangiectatic adenoma: an entity associated with increased body mass index and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24281

21 January 2018

Identifiers

DOI

10.1002/JMRI.24281

1 reference

11 May 2018

1 reference

11 May 2018